IL2 and lymphopenia: However, the role of brain metastases in patients treated with ICIs can be explained through several mechanisms such as activation of regulatory lymphocytes T (Treg), lymphopenia, reduction of T-cell responses, and deficiency of interleukin 2 (IL-2) signaling that result in an immunosuppressive microenvironment [47].